Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Vasc Res ; 32(4): 247-53, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7654881

RESUMO

Treatment of spontaneously hypertensive rats (SHR) with alpha-adrenoceptor antagonists failed to alter the development of hypertension in this animal model. However, agents such as captopril (CAP) and losartan (LOS) which interfere with the renin-angiotensin system effectively prevented the development of hypertension. When tolerance occurred in the presence of doxazosin (DOX) or phenoxybenzamine, there was an enhanced sensitivity to the blood pressure lowering influence of LOS. In the presence of CAP, at a dose that did not retard the development of blood pressure in the SHR, DOX treatment significantly offset the development of hypertension in this strain. These results suggest that a functional tolerance to agents that interfere with the sympathetic nervous system is mediated by the renin-angiotensin system. Angiotensin-converting enzyme inhibition was associated with a normalization of the enhanced contraction of the mesenteric vascular bed seen in preparations from the SHR and a suppression in the development of the vascular amplifier. The results suggest that the sympathetic nervous system is unable to maintain an elevated blood pressure in the SHR during interference with the functioning of the renin-angiotensin system. Conversely, under conditions of alpha-adrenoceptor blockade, angiotensin II can maintain an elevated blood pressure in the SHR.


Assuntos
Antagonistas Adrenérgicos alfa/uso terapêutico , Angiotensina II/fisiologia , Hipertensão/tratamento farmacológico , Animais , Compostos de Bifenilo/administração & dosagem , Compostos de Bifenilo/uso terapêutico , Pressão Sanguínea , Captopril/administração & dosagem , Captopril/uso terapêutico , Doxazossina/administração & dosagem , Doxazossina/uso terapêutico , Tolerância a Medicamentos , Hipertensão/fisiopatologia , Imidazóis/administração & dosagem , Imidazóis/uso terapêutico , Losartan , Norepinefrina/farmacologia , Fenoxibenzamina/administração & dosagem , Fenoxibenzamina/uso terapêutico , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Tetrazóis/administração & dosagem , Tetrazóis/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA